Back
Apellis Pharmaceuticals Stock Price Chart
ChatGPT admits...
Click here for details.
Buy
77
APLS
Apellis Pharmaceuticals
Last Price:
63.85
Seasonality Move:
8.4%
7 Day Trial
ALL ACCESS PASS
$
7
Something is Coming for America's Top Stock
Click here to learn its name and why.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.
Apellis Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 52.63 | Buy |
| 20-day SMA: | 49.6 | Buy |
| 50-day SMA: | 46.55 | Buy |
| 200-day SMA: | 60.79 | Buy |
| 8-day EMA: | 54.92 | Buy |
| 20-day EMA: | 51.08 | Buy |
| 50-day EMA: | 48.31 | Buy |
| 200-day EMA: | 53.74 | Buy |
Apellis Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.92 | Buy |
| Relative Strength Index (14 RSI): | 79.31 | Buy |
| Chaikin Money Flow: | 1819210 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (45.11 - 53.67) | Buy |
| Bollinger Bands (100): | (32.71 - 51.23) | Buy |
Apellis Pharmaceuticals Technical Analysis
| Nov 20 | Nov 21 | Nov 22 | Nov 24 | Nov 27 | Nov 28 | Nov 29 | Nov 30 | Dec 1 | Dec 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 20 | 21 | 22 | 24 | 27 | 28 | 29 | 30 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Apellis Pharmaceuticals Stock
Is Apellis Pharmaceuticals Stock a Buy?
- Apellis Pharmaceuticals share price is 63.89 while APLS 8-day simple moving average is 52.63, which is a Buy signal.
- The stock price of APLS is 63.89 while Apellis Pharmaceuticals 20-day SMA is 49.60, which makes it a Buy.
- Apellis Pharmaceuticals 50-day simple moving average is 46.55 while APLS share price is 63.89, making it a Buy technically.
- APLS stock price is 63.89 and Apellis Pharmaceuticals 200-day simple moving average is 60.79, creating a Buy signal.
APLS Technical Analysis vs Fundamental Analysis
Buy
77
Apellis Pharmaceuticals (APLS)
is a Buy
Is Apellis Pharmaceuticals a Buy or a Sell?
-
Apellis Pharmaceuticals stock is rated a Buy
The current Apellis Pharmaceuticals [APLS] share price is $63.89. The Score for APLS is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
Apellis Pharmaceuticals Stock Info
Market Cap:
7.57B
Price in USD:
63.89
Share Volume:
2.89M
Apellis Pharmaceuticals 52-Week Range
52-Week High:
94.75
52-Week Low:
19.83
Buy
77
Apellis Pharmaceuticals (APLS)
is a Buy
Apellis Pharmaceuticals Share Price Forecast
-
What is the Apellis Pharmaceuticals stock price today?
The Apellis Pharmaceuticals stock price is 63.89 USD today. -
Will APLS stock go up or go down?
Apellis Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Apellis Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Apellis Pharmaceuticals is not overvalued.
Is Apellis Pharmaceuticals Stock a Buy?
- Apellis Pharmaceuticals share price is 63.89 while APLS 8-day exponential moving average is 54.92, which is a Buy signal.
- The stock price of APLS is 63.89 while Apellis Pharmaceuticals 20-day EMA is 51.08, which makes it a Buy.
- Apellis Pharmaceuticals 50-day exponential moving average is 48.31 while APLS share price is 63.89, making it a Buy technically.
- APLS stock price is 63.89 and Apellis Pharmaceuticals 200-day simple moving average is 53.74, creating a Buy signal.
Fundamental Analysis of Apellis Pharmaceuticals
Is Apellis Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.55 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.57 per share, and an increase next year of $3.03 per share.
Technical Analysis of Apellis Pharmaceuticals
Should I short Apellis Pharmaceuticals stock?
- APLS Moving Average Covergence Divergence (MACD) indicator is 2.92, suggesting Apellis Pharmaceuticals is a Buy
- Apellis Pharmaceuticals Relative Strength Index (RSI) is 79.31, which suggest Apellis Pharmaceuticals is overbought
- The Bollinger Bands (25) for Apellis Pharmaceuticals is (45.11 - 53.67), which suggest Apellis Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Apellis Pharmaceuticals is (32.71 - 51.23), which suggest Apellis Pharmaceuticals is a Buy
* Apellis Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.